| Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia Cancer Genome Atlas Research Network New England Journal of Medicine 368 (22), 2059-2074, 2013 | 4716 | 2013 |
| Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing L Ding, TJ Ley, DE Larson, CA Miller, DC Koboldt, JS Welch, JK Ritchey, ... Nature 481 (7382), 506-510, 2012 | 2527 | 2012 |
| The origin and evolution of mutations in acute myeloid leukemia JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ... Cell 150 (2), 264-278, 2012 | 1833 | 2012 |
| Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology … MM Li, M Datto, EJ Duncavage, S Kulkarni, NI Lindeman, S Roy, ... The Journal of molecular diagnostics 19 (1), 4-23, 2017 | 1597 | 2017 |
| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 729 | 2018 |
| Assuring the quality of next-generation sequencing in clinical laboratory practice AS Gargis, L Kalman, MW Berry, DP Bick, DP Dimmock, T Hambuch, F Lu, ... Nature biotechnology 30 (11), 1033-1036, 2012 | 508 | 2012 |
| A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia GL Uy, MP Rettig, IH Motabi, K McFarland, KM Trinkaus, LM Hladnik, ... Blood, The Journal of the American Society of Hematology 119 (17), 3917-3924, 2012 | 429 | 2012 |
| Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ... Jama 314 (8), 811-822, 2015 | 381 | 2015 |
| Use of whole-genome sequencing to diagnose a cryptic fusion oncogene JS Welch, P Westervelt, L Ding, DE Larson, JM Klco, S Kulkarni, J Wallis, ... Jama 305 (15), 1577-1584, 2011 | 302 | 2011 |
| Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2 A Ungewickell, A Bhaduri, E Rios, J Reuter, CS Lee, A Mah, A Zehnder, ... Nature genetics 47 (9), 1056-1060, 2015 | 282 | 2015 |
| TBX6 null variants and a common hypomorphic allele in congenital scoliosis N Wu, X Ming, J Xiao, Z Wu, X Chen, M Shinawi, Y Shen, G Yu, J Liu, ... New England Journal of Medicine 372 (4), 341-350, 2015 | 278 | 2015 |
| Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux W Lu, AM Van Eerde, X Fan, F Quintero-Rivera, S Kulkarni, H Ferguson, ... The American Journal of Human Genetics 80 (4), 616-632, 2007 | 244 | 2007 |
| Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing Y Mochizuki, J He, S Kulkarni, M Bessler, PJ Mason Proceedings of the National Academy of Sciences 101 (29), 10756-10761, 2004 | 241 | 2004 |
| Clinical next‐generation sequencing in patients with non–small cell lung cancer IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ... Cancer 121 (4), 631-639, 2015 | 226 | 2015 |
| Optimizing cancer genome sequencing and analysis M Griffith, CA Miller, OL Griffith, K Krysiak, ZL Skidmore, A Ramu, ... Cell systems 1 (3), 210-223, 2015 | 221 | 2015 |
| Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML DC Link, LG Schuettpelz, D Shen, J Wang, MJ Walter, S Kulkarni, ... Jama 305 (15), 1568-1576, 2011 | 210 | 2011 |
| Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA J Zhang, J Li, JB Saucier, Y Feng, Y Jiang, J Sinson, AK McCombs, ... Nature medicine 25 (3), 439-447, 2019 | 203 | 2019 |
| Validation of a next-generation sequencing assay for clinical molecular oncology CE Cottrell, H Al-Kateb, AJ Bredemeyer, EJ Duncavage, DH Spencer, ... The Journal of molecular diagnostics 16 (1), 89-105, 2014 | 199 | 2014 |
| Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t (8; 13)(p11; q12) myeloproliferative syndrome A Reiter, J Sohal, S Kulkarni, A Chase, DHC Macdonald, RCT Aguiar, ... Blood, The Journal of the American Society of Hematology 92 (5), 1735-1742, 1998 | 190 | 1998 |
| Good laboratory practice for clinical next-generation sequencing informatics pipelines AS Gargis, L Kalman, DP Bick, C Da Silva, DP Dimmock, BH Funke, ... Nature biotechnology 33 (7), 689-693, 2015 | 164 | 2015 |
Eric DuncavageProfessor of Pathology and Immunology, Washington University School of Medicine在 wustl.edu 的电子邮件经过验证
